{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "37.00",
    "chg": 1.85,
    "chgp": "5.26%",
    "dir": 1,
    "prev_price": "35.15",
    "mcapval": "903.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE00TV01023",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": 300000,
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "1003813",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Sep-2026",
      "details": "The Trading Window of the Company shall remain closed with effect from October 12026 until the expiry of 48 hours after the declaration of financial results for the quarter and half year ended 30/Sept/2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Diversification / Disinvestment",
      "datetime": "28-Sep-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in conitinuation of the Companys letter dated 13/Aug/2026 regarding stake sale of 51% of the paid up capital of Ishwari Healthcare Private Limited unlisted subsidiary of the Company this is to inform you that the Company has completed sale of 209100 equity shares of Rs.10/- each held by the Company.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "22-Sep-2026",
      "details": "Please find enclosed the Scrutinizers Report on the business transacted at the 18th Annual General Meeting of the company held on Tuesday 22/SEPT/2026 through video conferencing / other audio-visual means.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News